Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Insulin Glargine U200 and U500 vs Lantus in T1DM
NCT02201199Phase 1Completed
- Sponsor
- Sanofi
- Start
- Aug 2014
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin glargine in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Sanofi. Primary endpoint: Area under the serum insulin glargine concentration curve over the first 12 hours. Started Aug 2014; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02201199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201199.